Company intelligence / Profile preview

Unison Capital

Tokyo, Japan

Ownership: Private
Development stage: Other

Overview

Unison Capital is a Japan-based private equity firm focusing on buyouts and growth investments in mid-market companies in Japan and Asia, with a strong focus on healthcare services and healthcare-related companies rather than developing its own drugs or therapies.[1][3][5][7][8][9]

Industry: Investors

Partnerships

Lupin (partnership via acquisition of Kyowa Pharmaceutical Industry through an Unison entity)[2][4]

Beyond the preview

Go deeper on Unison Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unison Capital.

Explore the full profile